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Abstract: We tested levodopa effects on lateralized direct and indirect semantic priming in 
40 healthy right-handed men in a placebo-controlled, double-blind procedure. Crucially, priming 
was also analyzed as a function of participants’ positive schizotypal features (magical ideation, 
MI), previously found to be associated with an enhanced semantic spreading activation (SSA) 
within the right hemisphere. Across both priming conditions, we observed increased semantic 
priming in the levodopa group 1) speciﬁ  cally after right visual ﬁ  eld stimulations and 2) in 
high MI scorers. In both instances, increased semantic priming emerged from exceedingly 
long reaction times to unrelated targets reﬂ  ecting 1) the left hemisphere’s specialization for 
closely related concepts and 2) an opposite association between MI and SSA in the levodopa 
as compared with the placebo group. As a ﬁ  nal ﬁ  nding, low MI scorers under levodopa per-
formed like high MI scorers under placebo. Our ﬁ  ndings speak against a general dopaminergic 
focusing of SSA, but one that respects each hemisphere’s specialization. They also suggest that 
individuals’ schizotypal features are important determinants of dopamine-induced changes in 
hemispheric functioning. We note that, in psychiatric patients, dopamine antagonists reportedly 
restore unusual lateralization. We discuss this dissociation between schizotypy and schizophre-
nia as supporting previous notions of protective brain mechanisms operating in the healthy 
“psychosis-prone” brain.
Keywords: schizophrenia, schizotypy, language, hemispheric asymmetries, dopamine, lexical 
decision paradigm
Introduction
Core features of schizophrenia are language and thought disturbances, of which loose 
associations have long been described (Bleuler 1911/50). Contemporary models pro-
pose that loose associations emerge from an enhanced semantic spreading activation 
(SSA) within cortical networks (Maher 1983; Spitzer 1997). This network model 
assumes that semantic concepts are neuronally represented as nodes. Semantic con-
cepts with a close relatedness are represented by nodes located close to each other 
and are strongly interconnected. For concepts with a weak semantic relatedness, 
nodes are located more distant from each other and the interconnections are rather 
weak and indirect. Whenever a given node is activated, the surrounding nodes will 
be activated to a degree related to their closeness to the initially activated node 
(Collins and Loftus 1975). Consequently, in patients producing loose associations, 
the SSA might proceed along new lines, reaching several widespread, only loosely 
interconnected nodes.
SSA is commonly tested with semantic priming paradigms, in which a word 
stimulus primes lexical decisions about a subsequent target stimulus (Meyer and 
Schvaneveldt 1971). For instance, if participants have to decide whether ORANGE Neuropsychiatric Disease and Treatment 2006:2(1) 72
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is a word or a non-word, they make faster decisions when 
this word was primed by the word LEMON (semantically 
related) than when it was primed by the word CHAIR 
(semantically unrelated). Supporting the idea of an increased 
SSA in schizophrenia, patients exhibited increased seman-
tic priming as compared with controls (Manschreck et al 
1988; Kwapil et al 1990). More recent studies suggest that 
“indirect” semantic priming (such as that from the word 
pair STRIPES–LION related by a third, mediating concept 
(TIGER) is a particularly sensitive measure of SSA (Spitzer, 
Braun, Hermle, et al 1993; Spitzer, Braun, Maier, et al 1993). 
This priming is enhanced overproportionally in patients with 
schizophrenia (see Spitzer 1997 for an overview). Indirect 
semantic priming effects in healthy participants are smaller 
than direct priming effects, corroborating the view that the 
amount of spreading activation is inversely related to the 
semantic distance (ie, number of related nodes) between the 
two semantic concepts. In thought-disordered patients, on the 
other hand, SSA appears to be increased to the degree that 
indirectly related targets are as easily detected as directly 
related targets.
Based on mathematical modeling of frontal cortical 
networks (Servan-Schreiber et al 1990), the Spitzer group 
suggested that dopamine (DA) increases signal-to-noise 
ratios and is thus a potent neuromodulator of SSA (Spitzer, 
Braun, Hermle, et al 1993; Spitzer 1997). Schizophrenia 
has been related to both a dysfunctional DA system 
(Davis et al 1991), and a hypofunctional frontal lobe 
system (Ingvar and Franzen 1974; Weinberger and 
Berman 1996). Taken together, according to Spitzer and 
colleagues (Spitzer, Braun, Hermle, et al 1993; Spitzer 
1997), a frontal hypodopaminergia would attenuate 
signal-to-noise ratios leading to inappropriate processing 
(ie, unduly increased SSA in the present case). The idea 
of DA focusing the SSA has been supported by a recent 
study with healthy participants, in which a levodopa 
supplementation attenuated indirect semantic priming 
(Kischka et al 1996).
Although these considerations sound straightforward, a 
recent review on semantic priming in schizophrenia points 
to many inconsistencies between studies (Minzenberg et al 
2002). These authors argue that the heterogeneous ﬁ  ndings 
might result from individual differences in clinical variables 
such as illness acuteness and duration, medication type, 
and symptom heterogeneity (p 716). Studies with healthy 
schizotypes circumvent such confounding variables. Apart 
from the notion that schizotypes might have a certain risk 
for later psychosis (Chapman et al 1994; Kwapil et al 1997), 
similarities between schizotypy and schizophrenia have been 
reported for numerous physiological and behavioral measures 
(eg, electrophysiology: Klein et al 1999; Pizzagalli et al 
2000; cognition: Gooding et al 1999; Park 1999; attention: 
Brugger and Graves 1997; Sarkin et al 1998; Mohr, Bracha, 
et al 2003; and motor system parameters: Shaw et al 2001; 
Barnett and Corballis 2002; Mohr, Thut, et al 2003) including 
language functions described in more detail in the following 
paragraph.
Moritz et al (1999) showed that semantic priming was 
enhanced in healthy participants demonstrating language 
distortions qualitatively reminiscent of those reported from 
patients with schizophrenia. In their study, semantic priming 
was unrelated to participants’ schizotypy scores as measured 
by the SPQ scale (Raine 1991). In line with clinical obser-
vations, these authors concluded that enhanced SSA was 
speciﬁ  cally found in persons showing more or less severe 
signs of thought-disorder (but see Minzenberg et al 2002, 
p 712f). Independent observations would suggest that nota-
bly positive schizotypal thought relates to enhanced SSA. 
Individuals’ scoring high on magical ideation (MI; Eckblad 
and Chapman 1983) 1) produced an increased amount of 
“loose” associations” (Duchêne et al 1998; Gianotti et al 
2001) and 2) showed an enhanced willingness to attribute 
relatedness to remotely associated words (Mohr et al 2001). 
Moreover, positive schizotypal individuals’ reaction times 
(RTs) to target words preceded by an indirectly related prime 
word were as brief as were those to targets preceded by 
directly related primes (Pizzagalli et al 2001). This increase 
in SSA was found, however, exclusively when targets were 
presented to the left visual ﬁ  eld (LVF)/right hemisphere (RH) 
but not when presented to the right visual ﬁ  eld (RVF)/left 
hemisphere (LH), mimicking observations from patients with 
thought-disorder (Weisbrod et al 1998). In both studies, such 
“loosening” of associations was suggested to emerge from 
overactive RH language functions preferring coarse as well 
as focused semantic analysis (see Rodel et al 1992; Beeman 
and Chiarello 1998; Faust and Lavidor 2003). In line with 
this suggestion, an “abnormally” high contribution of RH 
language processing was found in patients with schizophre-
nia (Sommer et al 2001, 2003) and healthy participants with 
positive schizotypal features (Brugger et al 1993; Leonhard 
and Brugger 1998).
It appears difﬁ  cult to reduce the two ideas of 1) a 
hypodopaminergic frontal lobe and 2) a hyperactive RH 
language system to a common denominator. In fact, if a 
hypodopaminergic frontal lobe attenuated signal-to-noise 
ratios, one would not assume in the first line that a Neuropsychiatric Disease and Treatment 2006:2(1) 73
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hyperactive RH language system caused “loosening” of 
associations. Of speciﬁ  c interest to the role of DA as differ-
ent for the two hemispheres of the brain is the ﬁ  nding that 
acutely psychotic patients and healthy positive schizotypal 
populations appear to have a relatively hyperactive RH 
DA system. This was inferred from convergent evidence 
in various behavioral paradigms for left-sided attentional 
biases (Harvey et al 1993; Brugger and Graves 1997) and 
systematic left-turning biases (Bracha et al 1993; Mohr, 
Bracha, et al 2003) in both acute psychotic patients and 
healthy schizotypes. A hyperactive RH DA system might 
thus cause loose associations by enhancing the salience of 
remotely associated concepts (see also Kapur 2003). As 
already suggested by Weisbrod et al (1998), a failure to 
establish LH language dominance in schizophrenia (Crow 
2000) might lead to an overproportional reliance on the 
RH language functions specialized for the analysis of both 
semantically strongly and weakly related concepts (Faust 
and Lavidor 2003). Analysis of weak associates would 
enter current lines of thought as “intrusions”. Weisbrod 
et al (1998) not only reported pronounced indirect semantic 
priming after LVF target presentations, but also after RVF 
presentations. Healthy controls and non-thought-disordered 
psychiatric patients did not show a comparable aberrant 
enhancement of SSA after RVF presentation. A more 
symmetrical language system in schizophrenia might cause 
a patient’s LH to reveal RH language processing, blurring 
division of labor between hemispheres, and consequently 
suppress primarily LH-mediated thought (see Weisbrod 
et al 1998, p 145).
Before accepting or rejecting one of two apparently 
contradictory ideas on dopaminergic modulation of SSA 
by the two hemispheres, direct dopaminergic inﬂ  uences 
have ﬁ  rst to be tested. We here assessed lateralized direct 
and indirect semantic priming in healthy participants, of 
whom half received levodopa and half a placebo. Further-
more, to test whether schizotypy would modulate potential 
effects of levodopa on lateralized semantic processing, each 
participant ﬁ  lled in the MI scale introduced by Eckblad 
and Chapman (1983) as an “indicator of schizotypy”. We 
predicted enhanced SSA, particularly after LVF presen-
tations, and more so for participants with elevated MI 
scores. These predictions are based on 1) the previous 
literature reviewed above (especially Bracha et al 1993; 
Harvey et al 1993; Brugger and Graves 1997; Weisbrod 
et al 1998; Pizzagalli et al 2001; Mohr, Bracha, et al 2003), 
2) the potential of dopaminergic drugs to trigger psychotic 
symptoms in normals (Sekine et al 2001) and worsen them in 
patients (Abi-Dargham et al 1998), and 3) the amelioration 
of thought-disorder and loose associations with neuroleptic 
treatment (Shimkunas et al 1967; Spohn et al 1986).
Methods
Subjects
A total of 40 healthy men were recruited on and around the 
campus of the University of Zurich by ﬂ  yers and personal 
contact. All participants were right-handed according 
to a 13-item handedness questionnaire (Chapman and 
Chapman 1987). Their mean age was 25.1 ± 3.8 years and 
their mean education was 16.9 ± 3.2 years. All contacted 
individuals also ﬁ  lled in a self-report questionnaire asking 
about current or previous medical, neurological, or psy-
chiatric histories (guidelines see Campbell 2000). Those 
indicating any current medication, history of previous or 
current drug abuse, or neuropsychiatric illnesses, were not 
further tested. Because of the potential of DA agonists to 
trigger psychotic symptoms (Abi-Dargham et al 1998; 
Sekine et al 2001), especially in individuals with high MI 
scores, those scoring in the upper quartile of this scale (MI 
scores   22; see next paragraph) were also excluded. The 
local Ethics Committee of the University Hospital Zurich 
had approved the study given this precaution would be 
taken. This exclusion was considered unlikely to drastically 
inﬂ  uence results, since neuropsychological performance 
patterns described in schizophrenia or healthy schizotypal 
individuals have even been observed in random samples of 
completely healthy participants as a function of MI scores 
(eg, Leonhard and Brugger 1998; Mohr et al 2001; Barnett 
and Corballis 2002; Mohr, Bracha, et al 2003; Mohr, 
Thut, et al 2003). After a complete study description, all 
participants gave written informed consent before partici-
pation. They were also paid 100 Swiss Francs after study 
completion (see Mohr et al 2004; Mohr, Krummenacher, 
et al 2005; Mohr, Landis, et al 2005 for additional data on 
the same individuals).
Questionnaires
MI scale
We assessed subjects’ MI with a validated 30-item 
questionnaire that included items such as “I sometimes 
have a feeling of gaining or losing energy when people 
look at me or touch me,” (keyed true) or “I have never had 
the feeling that certain thoughts of mine really belonged to 
someone else” (keyed false). Scores on the MI scale range 
from 0 to 30, higher scores indicating more pronounced 
magical thinking. The scale is published in full in Eckblad Neuropsychiatric Disease and Treatment 2006:2(1) 74
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and Chapman (1983) and in Barnett and Corballis (2002), 
and normative data can be found in Garety and Wessely 
(1994).
Double-blind procedure
The study was a randomized, double-blind, between-
subjects (levodopa/placebo) design. A dual-release formu-
lation of 200 mg levodopa/50 mg benserazide (Madopar® 
DR, Roche Pharma AG, Reinach, Switzerland) with fast 
absorption within the ﬁ  rst hour and sustained concentra-
tion levels thereafter (Gasser et al 1999) was administered. 
Prior to the study, subjects were informed about the 
experimental procedure and about possible side-effects of 
levodopa administration. Each subject fasted overnight and 
arrived at 0900 h on the day of the experiment. Subjects 
were also instructed not to consume alcohol or any other 
drugs for at least 24 hours prior to testing. After hav-
ing provided informed consent, subjects received either 
Madopar DR or a placebo. They consumed 200 ml of water 
directly after substance administration, and a standardized 
breakfast was provided 15 minutes later. In order to ensure 
that subjects were under signiﬁ  cant levodopa concentra-
tion throughout the experiment, 2 blood samples of about 
5–7 ml each were drawn. The ﬁ  rst blood sample was col-
lected 30 minutes after substance intake, just before the 
experiment started. The second blood sample was collected 
as soon as experiments were ﬁ  nished (about 120–150 
minutes after levodopa intake). For details on blood sample 
collection and analysis see Mohr et al (2004). The semantic 
priming study was conducted about 15 minutes after the 
ﬁ  rst blood sample.
Semantic priming task
All stimuli were letter strings between 3 and 7 characters. 
The 120 prime-target pairs had already been used in our 
previous study (Pizzagalli et al 2001), and were divided 
into 4 categories of prime-target relations. While all primes 
were nouns (n = 120), the target was a directly related noun 
(n = 20), an indirectly related noun (n = 20), an unrelated 
noun (n = 20), or a pronounceable non-word (n = 60). 
Thirty-nine participants not included in the subsequent 
study had rated the semantic relatedness between prime and 
target words on a 7-point scale (1 = unrelated, 7 = strongly 
related). The prime-target pairs of the three categories were 
highly signiﬁ  cantly different according to their semantic 
relatedness (F(2,57) = 1999.97; p  0.0001), with mean 
values of 6.66 ± 0.10 for directly related, 3.20 ± 0.42 for 
indirectly related, and 1.39 ± 0.17 for unrelated word pairs, 
respectively (all p values  0.0001). Emotionality as rated 
on a 7-point scale (1 = unemotional, 7 = highly emotional) 
by another 11 independent subjects did not differ between 
words of the different categories (F(2, 78) = 2.24, p = 0.11), 
with mean emotionality scores of 4.52 ± 0.99 for directly 
related, 4.41 ± 0.87 for indirectly related, and 4.08 ± 1.02 
for unrelated words. Words of the different categories did 
not differ with respect to word length and frequency of 
occurrence in German texts (Ruoff 1990).
Stimulus presentation.
There were 4 stimulus blocks, each consisting of 60 trials 
(prime-target pairs) belonging to 4 categories: 10 directly 
related, 10 indirectly related, 10 unrelated prime-target pairs, 
and 30 word/non-word pairs (making up a total of 240 trials). 
All prime words within each category were presented 
centrally on the computer screen. Half of the targets were 
presented to the LVF/RH and the other half to the RVF/LH. 
Across the 4 blocks each target appeared twice, once in 
each visual hemiﬁ  eld. Stimuli were presented white on a 
gray background. Target eccentricity was between 4° and 
8° of visual angle.
Each trial consisted of 3 displays following each other 
without time gaps: ﬁ  rst, a central ﬁ  xation cross appeared for 
1000 ms, replaced by a prime for 200 ms, also presented in 
the center of the screen. Subsequently, a lateralized target 
was presented for 150 ms while the central prime remained 
visible (as in Pizzagalli et al 2001). Thus, prime-target stimu-
lus onset asynchrony (SOA) was 200 ms, ensuring automatic 
rather than controlled processing (Neely 1991). The screen 
remained blank until the subject’s manual response initiated 
the next trial. Manual responses consisted of pressing 2 lateral 
keys simultaneously with both index ﬁ  ngers (on detecting a 
real word) or of pressing the space bar simultaneously with 
both thumbs (on detecting a non-word). Speed and accuracy 
were equally emphasized in the instructions, and number of 
correct responses and the corresponding RTs were automati-
cally recorded.
After 20 practice trials, each subject received the same 
pseudorandom sequence of trials, with the constraint that 
1) no more than 3 trials of the same category were presented 
consecutively, and 2) no more than 3 targets in the same 
visual ﬁ  eld were presented consecutively. A PC with ERTS 
software (BeriSoft Cooperation, Frankfurt, Germany) was 
used for stimulus presentation and RT recording. A chin and 
headrest kept the distance between subject’s eyes and the PC 
screen constant (55 cm). The subject performed the 4 blocks 
twice in succession with a rest of 10 minutes in between.Neuropsychiatric Disease and Treatment 2006:2(1) 75
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Data analysis
As in previous studies (Blum and Freides 1995; Passerieux 
et al 1997; Moritz et al 1999) priming effects were deter-
mined in the following way: the median RT of the experimen-
tal condition (direct or indirect semantic priming condition, 
respectively) was subtracted from the median RT of the unre-
lated condition. Consequently, a positive difference indicates 
a direct or indirect semantic priming effect, respectively. 
We also determined priming effects for accuracy data: mean 
number of correct responses in the direct or indirect semantic 
condition minus mean number of correct responses in the 
unrelated condition. Thus, a positive difference indicates a 
performance advantage for the direct or indirect semantic 
priming condition, respectively.
Semantic priming effects for subtle differences in prime-
target relationships (direct, indirect) are not necessarily detected 
when comparing medians/means of several groups with mul-
tivariate analysis of variance (ANOVAs). Thus, following 
previous studies (Kwapil et al 1990; Spitzer, Braun, Hermle, 
et al 1993; Spitzer, Braun, Maier, et al 1993; Kischka et al 1996; 
Weisbrod et al 1998; Pizzagalli et al 2001), we performed the 
following statistical comparisons on the semantic priming data: 
(a) to test whether a semantic priming effect was present at all, 
we planned one-group t-tests against zero separately for each 
condition, substance group, MI group, and visual ﬁ  elds. Given 
the small sample sizes, we applied conservative, non-parametric 
Wilcoxon matched pairs tests; (b) the difference scores on RT 
and accuracy, respectively, were each subjected to separate 
4-way ANOVAs with substance groups (levodopa vs placebo) 
and MI groups (low vs high) as between-subject factors, and 
visual ﬁ  eld (RVF and LVF) and experimental condition (direct 
and indirect semantic priming) as repeated measures; (c) dif-
ference scores do not indicate whether signiﬁ  cant differences 
emerge from a superior performance for directly or indirectly 
related prime-target pairs or from enhanced RTs for unrelated 
prime-target pairs. Thus, we performed analogous ANOVAs 
as described in (b), but with the three prime-target pairs as 
repeated measures. Post-hoc single comparisons were conducted 
using Newman-Keuls Tests correcting for multiple comparison. 
All p values are, if not otherwise stated, two-tailed.
Due to an error in the randomization of placebo and 
levodopa, 21 participants were in the placebo group 
and 19 subjects in the levodopa group. Furthermore, we 
excluded 2 participants. Subsequent to testing, 1 participant 
was identiﬁ  ed as a native French speaker (see also Mohr, 
Krummenacher, et al 2005). The other participant produced 
extreme outliers for the directly related (LVF: 744.5 ms; RVF: 
862.3 ms) and indirectly related (LVF: 863 ms, RVF: 662 
ms) conditions (difference scores of the remaining individu-
als were, for the directly related condition, 148.4 ms ± 130.5 
ms (LVF) and 172.3 ms ± 137.5 ms (RVF) and, for the indi-
rectly related condition, 66.4 ms ± 102.7 ms (LVF) and 96.0 
ms ± 116.7 ms (RVF). Thus, analyses were performed on 18 
participants in the levodopa group and 20 participants in the 
placebo group. To perform parametric testing, we ascertained 
that all dependent variables were normally distributed (Kol-
mogorov-Smirnov Tests: all d values   0.14, all p values   
0.20).
Results
Subjects
The mean (±SD) MI score of the whole population was 
7.3 ± 5.2 (range: 1–21). A split at the median scale score (6) 
produced a high (n = 20, placebo: n = 1; levodopa: n = 9) 
and low (n = 18, placebo: n = 9, levodopa: n = 9) MI group. 
Three separate 3-way ANOVAs with substance groups 
and MI groups as between-group factors on 1) MI groups, 
2) age, and 3) years of education showed no signiﬁ  cant main 
effect for age and years of education, and no interactions 
(all F values  0.30, all p values  0.60, see Table 1). The 
levodopa blood serum concentrations in the placebo group 
were zero. A 2-way ANOVA for the levodopa group with 
MI groups as between-subject measure on levodopa blood 
serum concentrations for the ﬁ  rst and second blood sampling 
Table 1 Descriptive data of the study sample
Levodopa group Placebo group
Low MI group High MI group Low MI group High MI group
MI scores 3.3 ± 1.0 9.6 ± 5.0 3.4 ± 1.5 11.9 ± 4.6
Age (yr) 24.9 ± 4.4 24.4 ± 4.9 25.6 ± 3.1 25.7 ± 3.6
Education (yr) 15.4 ± 3.4 16.7 ± 3.4 18.2 ± 2.9 17.1 ± 3.3
Levodopa T1 (ng/ml) 203.3 ± 171.9 239.7 ± 284.9 ––
Levodopa T2 (ng/ml) 128.2 ± 123.0 159.7 ± 192.0 ––
Abbreviations: MI, magical ideation; T1/T2, levodopa blood serum concentration of the ﬁ  rst (T1) and second (T2) blood sample.Neuropsychiatric Disease and Treatment 2006:2(1) 76
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as repeated measure was not signiﬁ  cant (F values  0.002, 
p values   0.95, see Table 1). None of the subjects reported 
any remarkable substance-induced side-effects.
Semantic priming task
Presence of semantic priming effects (see data 
analysis, part a)
Semantic priming effects (Table 2) in the placebo group 
occurred for directly related prime-target pairs in both MI 
groups and visual ﬁ  elds. For indirectly related prime-target 
pairs, however, the difference score against zero was not 
signiﬁ  cant for the low MI group after RVF presentation and 
for the high MI group after LVF presentation (Table 2, bold 
print). Thus, unrelated and indirectly related prime-target 
pairs yielded comparably long RTs by low MI participants 
when projected to the RVF (LH) and comparably fast RTs 
by high MI participants when projected to the LVF (RH). 
As opposed to the placebo group, 1) high MI scorers in the 
levodopa group showed signiﬁ  cant semantic priming effects 
for each visual ﬁ  eld and 2) low MI scorers in the levodopa 
group did not show indirect semantic priming after LVF 
presentation (Table 2, bold print).
Accuracy
The ANOVA on the difference score (see data analysis, 
part b) showed a signiﬁ  cant main effect for substance groups 
(F(1, 34) = 4.36, p = 0.04); the difference score was higher 
in the levodopa (10.6 ± 5.4) than placebo (7.3 ± 0.0) group. 
Visual inspection of the mean accuracy for each prime-target 
pair condition indicated that this enhanced semantic priming 
effect resulted from a low detection accuracy for speciﬁ  cally 
the unrelated prime-target pairs (21.1 ± 8.1; placebo: 25.9 ± 7.2) 
rather than from a high detection accuracy for the directly 
related pairs (35.1 ± 4.8; placebo: 36.3 ± 4.8) or the indi-
rectly related pairs (30.2 ± 6.5; placebo: 28.3 ± 6.5). There 
was also a signiﬁ  cant main effect for experimental condition 
(F(2,34) = 106.35, p   0.0001) showing that the difference 
score was higher for directly related (12.1 ± 6.3) than indirectly 
related (5.7 ± 4.2) prime-target pairs.
The ANOVA on mean accuracy for the three prime-target 
conditions separately (see data analysis, part c) showed 
signiﬁ  cant main effects for target conditions (F(2,68) = 125.38, 
p   0.0001: directly related (35.7 ± 4.8)   indirectly related 
(29.3 ± 6.5)   unrelated prime-target pairs (23.6 ± 7.9)) 
and visual ﬁ  eld (F(1,34) = 6.59, p = 0.01: RVF (30.6 ± 5.5) 
  LVF (28.5 ± 7.2)). The interaction between substance and 
MI groups (F(1,34) = 4.89, p = 0.03) indicated that the high 
MI individuals tended to make less correct lexical decisions 
in the levodopa (25.7 ± 6.1) than placebo (32.2 ± 4.3) group 
(p = 0.07). Lexical decision performance by the low MI 
individuals did not differ between the levodopa (30.6 ± 4.7) 
and placebo (29.1 ± 7.1) group (p = 0.55).
Reaction times
The ANOVA on the difference score (see data analysis, 
part B) revealed a significant main effect for target 
condition (F(1,34) = 45.67, p   0.0001, directly related 
(160.4 ms ± 106.3 ms)  indirectly related prime-target 
condition (81.2 ms ± 86.8 ms)). In line with the accuracy 
data, the levodopa group tended to have stronger semantic 
Table 2 Mean median RTs (ms, ± SD) and priming effects of the high and low MI groups in the levodopa and placebo group, respectively
Levodopa group Placebo group
High MI Low MI High MI Low MI
LVF/RH DIR 655.3 ± 101.6 627.9 ± 108.9 600.7 ± 85.0 727.3 ± 173.7
IND 736.5 ± 156.0 738.6 ± 179.6c 660.7 ± 130.8 808.2 ± 283.6
UNR 829.5 ± 158.1 742.3 ± 127.7 708.1 ± 144.1 934.0 ± 362.1
Diff DIR 174.2 ± 77.6b 114.4 ± 94.2b 107.5 ± 118.9b 206.7 ± 195.0b
Diff IND 93.0 ± 85.3a 3.7 ± 117.3 47.5 ± 81.9 125.8 ± 98.4b
RVF/LH DIR 595.7 ± 112.3 592.8 ± 78.0 590.6 ± 84.1 690.5 ± 119.3
IND 687.9 ± 116.5 684.4 ± 94.3 632.5 ± 135.7 777.6 ± 166.2
UNR 890.5 ± 116.4 782.9 ± 158.8 689.6 ± 156.5 812.0 ± 173.5
Diff DIR 294.8 ± 84.2b 190.2 ± 130.9b 99.0 ± 132.0a 121.5 ± 118.2a
Diff IND 202.6 ± 110.1b 98.6 ± 129.9a 57.1 ± 79.5a 34.4 ± 83.8
ap   0.05, bp   0.01, signiﬁ  cant unprotected 2-tailed t-tests of semantic priming effects against zero (see also Spitzer, Braun, Hemle, et al 1993; Spitzer, Braun, Maier, et al 1993; 
Weisbrod et al 1998).
cBold numbers indicate those response latencies which are discussed in more detail in the text. 
Abbreviations: Diff, difference values (ms); DIR, directly related targets; IND, indirectly related targets; LVF, (left visual ﬁ  eld)/RH (right hemisphere); MI, magical ideation; 
RT, reaction time; RVF, (right visual ﬁ  eld)/LH (left hemisphere); UNR, unrelated targets.Neuropsychiatric Disease and Treatment 2006:2(1) 77
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priming effects (146.4 ms ± 92.0 ms) than the placebo 
group (97.7 ms ± 83.6 ms; F(1,34) = 3.00, p = 0.09). 
Again, visual inspection of mean RT data for each prime-
target condition showed that this enhanced priming effect 
in the levodopa group resulted mainly from longest RTs 
for unrelated prime-target pairs (811.3 ms ± 137.1 ms; 
placebo: 777.2 ms ± 209.2 ms), and shortest RTs for directly 
related prime-target pairs (617.9 ms ± 93.9 ms; placebo: 
646.6 ms ± 121.6  ms). RTs for indirectly related prime-target 
pairs were intermediate in both substance groups (levodopa: 
711.8 ms ± 126.0 ms; placebo: 712.8 ms ± 175.7 ms). The 
signiﬁ  cant interaction between substance and MI groups 
(F(1,34) = 6.21, p = 0.02) reﬂ  ected the fact that high MI 
scorers in the levodopa group had a stronger semantic 
priming effect than 1) high MI scorers in the placebo group 
(p = 0.03), and 2) low MI scorers in the levodopa group 
(p = 0.06, Figure 1, top panel). The interaction between sub-
stance group and visual ﬁ  eld (F(1,34) = 14.52, p = 0.0006) 
showed that semantic priming effects in the levodopa group 
were especially pronounced after RVF target stimulation 
(in fact signiﬁ  cantly larger than in any other condition; all 
p values   0.02, see Figure 2, top panel).
The ANOVA on RTs for the three prime-target conditions 
separately (see data analysis, part c) showed a signiﬁ  cant 
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Figure 1 In the upper part of the ﬁ  gure, mean semantic priming effects (ms) collapsed over directly and indirectly related prime-target pairs are displayed for the levodopa 
and placebo group separately for the two MI groups. In the lower part of the ﬁ  gure, the contribution of the different prime-target conditions to the overall semantic priming 
effect shown in the upper part is displayed, again separately for the two MI groups. These lower graphs demonstrate the crucial contribution of unrelated prime-target pairs 
in the high MI group to the increased semantic priming effect in the levodopa group (note that priming is expressed as the difference between RTs to unrelated and those 
to related prime-target pairs). Vertical bars denote SE.
Abbreviations: DIR, directly related targets; IND, indirectly related targets; MI, magical ideation; RT, reaction time; UNR, unrelated targets.Neuropsychiatric Disease and Treatment 2006:2(1) 78
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main effect for prime-target condition (F(2,68) = 69.88, 
p   0.0001) conﬁ  rming that fastest RTs were obtained from 
directly related prime-target pairs (633.0 ± 108.9), followed 
by indirectly related prime-target pairs (712.1 ± 152.2), and 
ﬁ  nally unrelated prime-target pairs (793.4 ± 177.2). There 
was a signiﬁ  cant interaction between prime-target condition, 
MI group and substance group (F(2,68) = 3.96, p = 0.02). To 
uncover the nature of this triple interaction, we calculated 
two ANOVAs, one for each substance group, with MI group 
as between-group factor and prime-target condition as the 
repeated measure. The ANOVA for the placebo group 
showed differences in semantic priming effects between 
all prime-target conditions (F(2,36) = 24.83, p   0.0001; 
all p values   0.002, see Figure 1 bottom) and a signiﬁ  cant 
main effect for MI group (F(1,18) = 4.46, p   0.05; high MI 
group shorter RTs than low MI group). The ANOVA for 
the levodopa group again showed a signiﬁ  cant main effect 
for prime-target condition (F(2,32) = 46.00, p   0.0001, all 
p values   0.002, see Figure 1, bottom), but also a signiﬁ  -
cant interaction with MI group (F(2,32) = 3.34, p   0.05). 
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Figure 2 In the upper part of the ﬁ  gure, mean semantic priming effects (ms) collapsed over directly and indirectly related prime-target pairs are displayed for the levodopa 
and placebo group separately for the two visual ﬁ  elds. In the lower part of the ﬁ  gure, the contribution of the different prime-target conditions to the overall semantic priming 
effect shown in the top part is displayed, again separately for the two visual ﬁ  elds. These lower graphs demonstrate the crucial contribution of unrelated prime-target pairs 
after RVF presentation to the increased semantic priming effect in the levodopa group (note that priming is expressed as the difference between RTs to unrelated and those 
to related prime-target pairs). Vertical bars denote SE.
Abbreviations: DIR, directly related targets; IND, indirectly related targets; LVF, left visual ﬁ  eld; RH, right hemisphere; RT, reaction time; RVF, right visual ﬁ  eld; LH, left hemisphere; 
UNR, unrelated targets.Neuropsychiatric Disease and Treatment 2006:2(1) 79
Semantic priming, dopamine and schizotypy
In the high MI group, all differences between prime-target 
conditions were signiﬁ  cant (all p values   0.02). In the low MI 
group, however, indirectly related and unrelated prime-target 
pairs were responded to with comparable speed (p = 0.19). 
Figure 1 (bottom) shows that RTs to unrelated prime-target 
pairs were particularly elevated in high MI, but not in the 
low MI subjects.
Finally, there was a significant interaction between 
visual ﬁ  eld, prime-target condition, and substance groups 
(F(2,68) = 7.48, p = 0.001). To uncover the nature of this 
triple interaction, we again calculated two ANOVAs, one 
for each substance group, with visual ﬁ  elds and prime-
target condition as the repeated measures. The ANOVA for 
the placebo group showed only the signiﬁ  cant main effect 
for prime-target condition (F(2,38) = 23.59, p   0.0001, 
all post-hoc p-values   0.002). The ANOVA for the 
levodopa group again showed the signiﬁ  cant main effect 
for prime-target condition (F(2,34) = 40.43, p  0.0001, 
all p values  0.0003), but also a signiﬁ  cant interaction 
with visual ﬁ  eld (F(2,34) = 10.88, p = 0.0002). All post-
hoc comparisons were signiﬁ  cant, indicating that RTs to 
directly and indirectly related prime-target pairs were shorter 
when presented to the RVF than LVF, but RTs to unrelated 
prime-target pairs were shorter when presented to the LVF 
than RVF. These particularly long RVF RTs explain the 
increased semantic priming effect for the levodopa group: the 
magnitude of the difference score is clearly due to the par-
ticularly long RTs to unrelated prime-target pairs and not to 
particularly short RTs to related prime-target pairs (whether 
directly or indirectly related; Figure 2 bottom).
Discussion
We investigated, in a double-blind, between-subject 
(levodopa/placebo) design with healthy right-handed men the 
inﬂ  uence of DA on lateralized semantic priming for directly 
related, indirectly related, and unrelated prime-target pairs. 
We also analyzed task performance as a function of indi-
viduals’ positive schizotypal features. Three major ﬁ  ndings 
emerged that we will address now in turn:
First, semantic priming effects were stronger in the 
levodopa than in the placebo group. This result is oppo-
site to what would be predicted by the model by Spitzer 
and collegues (Spitzer, Braun, Hermle, et al 1993; Spitzer 
1997), which proposes increased semantic priming under a 
hypo- rather than a hyper-dopaminergic state (see Spitzer, 
Braun, Hermle, et al 1993, Figures 7 and 8). The present 
experiment did not produce evidence for an improved task 
performance in the levodopa group, neither for directly 
nor indirectly related prime-target pairs. Rather, the major 
ﬁ  nding concerned unrelated prime-target pairs, which were 
responded to less accurately and with the longest RTs.
Second, the stronger semantic priming effects in the 
levodopa compared with the placebo group were prominently 
found after RVF presentations and in the participants with 
elevated positive schizotypy scores (high MI scorers). Thus, 
dopaminergic modulation of SSA depended on the hemi-
sphere of target presentation and on individuals’ schizotypal 
features (see discussion below).
Finally, the performance pattern of low and high MI 
scorers in the levodopa group was the mirror image of that 
displayed by the high and low MI scorers, respectively, in 
the placebo group. After placebo supplementation, high MI 
scorers treated indirectly related and unrelated prime-target 
pairs equally fast after LVF presentations (see also Pizzagalli 
et al 2001), a behavior observed in low MI scorers in the 
levodopa group. In contrast, high MI scorers in the levodopa 
group responded slowly to unrelated prime-target pairs 
(both visual ﬁ  elds) resulting in signiﬁ  cant direct and indirect 
semantic priming effects, again similar to the behavior of low 
MI scorers in the placebo group.
Before discussing these major ﬁ  ndings in more detail, 
we emphasize that participants’ performance was compa-
rable to that of healthy participants reported in previous 
studies using comparable designs: 1) superior lexical 
decision performance was obtained for RVF/LH than 
LVF/RH stimulus presentation (Pizzagalli et al 2001; 
Coney 2002; Faust and Lavidor 2003), 2) RTs were fast-
est and accuracy was highest for directly related prime-
target pairs, followed by indirectly related prime-target 
pairs, and ﬁ  nally unrelated prime-target pairs (Moritz 
et al 1999; Pizzagalli et al 2001; Coney 2002; Faust and 
Lavidor 2003), and 3) semantic priming (RTs, accuracy) 
was stronger for directly related than indirectly related 
prime-target pairs (Moritz et al 1999; Pizzagalli et al 2001; 
Faust and Lavidor 2003).
Levodopa effects on semantic priming 
performance
Accuracy
In accordance with our own observation, Kischka et al (1996) 
had reported a higher error rate in their levodopa (2.7%) com-
pared with their placebo (1.4%) group. Unfortunately, error 
rate in their study was low, preventing the authors to report 
error rates for the different prime-target conditions separately. 
In the present study, error rates were much higher (23.0% 
in the placebo group and 29.6% in the levodopa group) Neuropsychiatric Disease and Treatment 2006:2(1) 80
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than those repeatedly obtained from the prime-target pairs 
used by Spitzer and coworkers (Spitzer, Braun, Hermle, 
et al 1993; Spitzer, Braun, Maier, et al 1993; Kischka et al 
1996; Kiefer et al 1998; Weisbrod et al 1998). Error rates 
in the present study increased linearly (see Result section) 
from least errors for directly related prime-target pairs in 
the placebo group to most errors for unrelated prime-target 
pairs in the levodopa group. In the studies performed by the 
Spitzer group, all stimuli were presented centrally (Spitzer, 
Braun, Hermle, et al 1993; Spitzer, Braun, Maier, et al 1993; 
Kischka et al 1996; Kiefer et al 1998). Since targets in our 
study were presented lateralized, task demands were more 
challenging and automatically resulted in a higher error rate. 
However, we note that lateralized target presentation in the 
Weisbrod et al (1998) also yielded relatively low error rates. 
Thus, the higher error rate in our study may additionally be 
a consequence of the stimulus pairs, exposure duration of 
the targets (150 ms in the present study, 200 ms in Weisbrod 
et al 1998), or target eccentricity (visual angle was between 
4° and 6° in the present study, but around 2° in Weisbrod 
et al 1998).
In summary, whether accuracy was almost at ceiling 
(Kischka et al 1996) or lower as in the present study, a 
levodopa supplementation had a detrimental effect on word 
recognition performance in healthy populations. Such a 
decrease in word detection accuracy under an enhanced DA 
availability, unless speciﬁ  c to unrelated prime-target pairs, 
speaks very clearly against the idea that DA generally focuses 
SSA in cortical networks for lexical-semantic analysis 
(Spitzer, Braun, Hermle, et al 1993). To further account for 
this argument, further studies should report accuracy data 
for all prime-target pairs separately.
Reaction times
In previous studies (Kischka et al 1996; see also Copland 
et al 2003), diminished semantic priming effects after 
levodopa intake were silently assumed to reflect a 
decrease in SSA, without considering the necessity to 
inspect reaction times for the different prime-target pairs 
separately. Little if any attention was thus paid to the 
fact that a decrease in priming may have emerged from 
faster responding to unrelated prime-target pairs and not 
from slowed responding to indirectly related prime-target 
pairs (Kischka et al 1996) or to prime-target pairs with 
subordinate meanings (Copland et al 2003). It has been 
argued that only difference scores that are weighted for RTs 
to unrelated prime-target pairs are relevant for inferences 
about SSA (eg, Kwapil et al 1990, p 220). However, the 
Spitzer, Braun, Hermle, et al model (1993, figures 7 
and 8), within which much work has been framed, does 
not predict that DA shortens distances between concepts 
in semantic space. Since diminished semantic priming 
in the levodopa groups (see Kischka et al 1996; Copland 
et al 2003) emerged from fast responding to unrelated 
prime-target pairs, we have to assume that unrelated targets 
became easily accessible under a “higher-than-normal” 
DA availability. This assumption would imply that either 
SSA increased under a heightened DA availability or the 
distances between semantic concepts may have shrunk 
(ie, facilitating efﬁ  cient access to speciﬁ  cally remotely 
separated nods).
In the present study, however, we did not observe espe-
cially fast RTs to unrelated prime-target pairs in the levodopa 
group. We rather found the opposite: unrelated prime-target 
pairs yielded longest RTs in the levodopa group, speciﬁ  cally 
after RVF presentation. Different processing styles may be 
at work when targets are presented either centrally or later-
alized, probably explaining the inconsistencies between the 
previous studies (Kischka et al 1996; Copland et al 2003) 
and the present one as well as between theoretical assump-
tions and empirical observations as just discussed above. 
When targets are presented centrally, both hemispheres 
interact in processing the incoming information. On the 
other hand, when targets are presented lateralized to only 
one visual hemi-ﬁ  eld, the contralateral hemisphere receives 
the information ﬁ  rst. It is here where functional hemispheric 
asymmetry in semantic processing enters the picture. Each 
hemisphere would engage in the processing of those associa-
tive relationships it is specialized for: the RH would dominate 
the course analysis of both close and remote associations 
and the LH that of close associations (see Rodel et al 1992; 
Beeman and Chiarello 1998; Faust and Lavidor 2003). Thus, 
slowed responding to unrelated targets after RVF presenta-
tion may have occurred because the LH is specialized for 
close associations, rendering access to remote associations 
more difﬁ  cult under a “higher-than-normal” DA availability 
(see Figure 2). DA may increase the signal-to-noise ratio in 
semantic networks, but it does so in different ways for the two 
hemispheres, probably in response to qualitative differences 
between the hemispheres in receptive language functions 
(Taylor and Regard 2003).
Weisbrod et al (1998) found strong indirect semantic 
priming effects after LVF target presentations, but an indi-
rect semantic priming effect after RVF presentation only in 
thought-disordered patients. Visual inspection of RT data 
indicate that it took thought-disordered patients a long time Neuropsychiatric Disease and Treatment 2006:2(1) 81
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to respond to indirectly and unrelated targets after RVF 
presentations, but RTs to directly related and indirectly 
related targets after LVF presentation were relatively fast. 
Patients with schizophrenia are assumed to suffer from 
a frontal “hypodopaminergia” (Davis et al 1991) and the 
patients in the Weisbrod et al (1998) study were all under 
DA antagonistic treatment. Consequently, longer RTs for 
remotely associated concepts after RVF presentation were 
found in patients during an even “lower-than-normal” DA 
availability. Conversely, in our healthy populations, 
prolonged RTs for remotely associated concepts after RVF 
presentation were observed under a “higher-than-normal” 
DA availability.
Facing this pharmacological dissociation between 
healthy and psychiatric populations, we point to previ-
ous reports from schizophrenia research, which suggest a 
neuroleptic modulation of semantic priming (Barch et al 
1996; Goldberg et al 2000) and note that most semantic 
priming studies tested patients under neuroleptic treatment 
(eg, Spitzer, Braun, Hermle, et al 1993; Spitzer, Braun, 
Maier, et al 1993; Weisbrod et al 1998; medication not 
reported). Concerning accuracy, Kwapil et al (1990), for 
instance, presented targets centrally and kept accuracy 
levels around 50% (which would be close to the error 
rate obtained in our study, in particular in the levodopa 
group). These authors’ patients with schizophrenia 
performed worse to unrelated prime-target pairs and 
superior to related prime-target pairs when compared 
with patients with bipolar disorders or healthy controls. 
Fifteen out of the 21 patients with schizophrenia were 
under neuroleptic medication. Thus, increased semantic 
priming was observed under a “lower-than-normal” DA 
availability with improved task performance for closely 
related prime-target pairs and, critically, inferior task per-
formance for unrelated prime-target pairs. These patients 
showed lowered task accuracy to unrelated prime-target 
pairs, as did our healthy population after a DA agonist. 
With respect to RTs, Barch et al (1996) investigated the 
inﬂ  uence of neuroleptic treatment on semantic priming. 
They found increased semantic priming with increased 
concentrations of neuroleptic treatment (at stimulus onset 
asynchronies below 950 ms). The higher DA antagonistic 
treatment doses, the higher was the difference between 
RTs to directly related and unrelated prime-target pairs, 
which was interpreted as a facilitated access to concepts in 
semantic networks. Unfortunately, a differential inﬂ  uence 
of DA on the processing of directly related vs unrelated 
prime-target pairs cannot be ascertained in retrospect, 
since conclusions in the Barch et al (1996) study were 
drawn from regression analyses. Finally, Goldberg et al 
(2000) tested priming effects for highly related, moder-
ately related, and low related intracategorical prime-target 
pairs as a function of medication status in patients with 
schizophrenia. The authors observed increased priming for 
highly related and low related word pairs when patients 
were on medication, while no priming was evident when 
patients were withdrawn from medication.
In summary, ﬁ  ndings from these clinical studies indicate 
an increase in semantic priming in patients under DA antago-
nistic treatment. This observation is in obvious opposition 
to our observation of increased semantic priming in the 
levodopa group compared with the placebo group, in particu-
lar after RVF presentations. However, the pharmacological 
dissociation discussed herein needs replication from future 
studies testing the modulating role of medication in patients 
with schizophrenia and DA challenges in schizotypal indi-
viduals on lateralized semantic priming performance.
Magical ideation
Healthy participants’ MI scores in the two substance 
groups markedly modulated lateralized semantic priming 
performance. In the levodopa group, high MI scorers were 
least accurate and showed increased semantic priming due 
to excessively long RTs to unrelated prime-target pairs. 
Most interestingly, comparably slow responding was not 
observed in any of the remaining conditions: First, in 
the placebo group, high MI scorers responded generally 
faster than low MI scorers. Second, high MI scorers in the 
levodopa group responded to directly and indirectly related 
prime-target pairs faster than did the low MI scorers in the 
levodopa group and the high MI scorers in the placebo 
group (see Figure 1). Thus, the experimentally induced 
hyperdopaminergia in high MI scorers appeared to have 
impaired access to most remotely related (ie, unrelated) 
prime-target pairs. This observation is important, given 
that participants with elevated positive schizotypal scale 
scores have repeatedly been shown to access remote 
semantic associations more efﬁ  ciently than low MI scorers 
(Gianotti et al 2001; Mohr et al 2001; Pizzagalli et al 
2001). On the basis of these observations we had originally 
expected high MI scorers to show even more pronounced 
SSA when treated with a DA agonist. However, access 
to remote associations was rather attenuated in high MI 
scorers after a DA agonist. In the placebo group, high MI 
scorers showed high SSA after LVF presentations; they 
responded fast to both indirectly and unrelated prime-target Neuropsychiatric Disease and Treatment 2006:2(1) 82
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pairs, which resulted in a non-signiﬁ  cant indirect semantic 
priming effect. This absence of priming is unlikely the 
result of long RTs to indirectly related prime-target pairs, 
since these participants showed fastest responding to 
unrelated prime-target pairs, suggesting facilitated access 
to the most extreme form of “remote associations”, ie, the 
absence of relatedness. We have interpreted this exagger-
ated availability to extreme remotedness/unrelatedness as 
a consequence of an increased SSA within RH-mediated 
semantic network functioning (Gianotti et al 2001; Mohr 
et al 2001; Pizzagalli et al 2001). Low MI scorers, on the 
other hand, showed both direct and indirect semantic prim-
ing after LVF presentation (see Table 2); they responded 
particularly slowly to unrelated prime-target pairs, argu-
ably to a focusing of SSA that rendered access to unrelated 
targets more difﬁ  cult. Low MI scorers revealed a generally 
more focused SSA; after RVF presentation, they did not 
show indirect semantic priming due to relative long RTs 
to both indirectly related and unrelated prime-target pairs 
(see Table 2). Thus, in the substance-free state, high MI 
scorers may have proﬁ  ted from enhanced SSA within the 
RH, while low MI scorers showed focused SSA within both 
hemispheres, but more prominently within the LH.
In the levodopa group, high MI scorers did not show this 
advantage for remotely associated targets, neither after LVF 
nor RVF presentations (Table 2). This ﬁ  nding suggests that 
DA focuses SSA in participants for whom an increased SSA 
in the substance-free state has been proposed (Gianotti et al 
2001; Mohr et al 2001; Pizzagalli et al 2001). Unexpected 
was the observation in the levodopa group that SSA was 
enhanced for low MI scorers after LVF presentation; they 
performed like high MI scorers in the placebo group (Table 2; 
see also Mohr et al 2004; Mohr, Landis, et al 2005). Thus, 
the performance pattern of low and high MI scorers in the 
levodopa group was the mirror image of that observed in 
high and low MI scorers, respectively, in the placebo group. 
Consequently, levodopa did not focus SSA in a general way, 
but decreased it for high MI scorers and increased it for low 
MI scorers. Given that this reversal was originally unexpected 
(but see Mohr, Krummenacher, et al 2005; Mohr, Landis, 
et al 2005 for similar ﬁ  ndings obtained from the same par-
ticipants using different paradigms), we can presently only 
speculate about its nature.
In patient populations, behavioral and attentional 
asymmetries, and by inference, neurochemical asymmetries 
were found to be attenuated or even reversed after 
treatment with DA antagonists (Tomer and Flor-Henry 
1989; Maruff et al 1995; Levine et al 1997; Purdon and 
Flor-Henry 2000). While functional interhemispheric 
balance might have been restored by DA decrease in 
patients, a similar balancing may occur by DA agonists 
in healthy subjects with high MI scores. This dissocia-
tion between schizotypy and schizophrenia suggests the 
existence of neurochemical differences between these 
populations, at least with regard to positive symptoms. 
Levodopa seemed to have restored interhemispheric DA 
symmetry for high MI scorers, instead of exaggerating 
asymmetries (see Mohr et al 2004; Mohr, Krummenacher, 
et al 2005; Mohr, Landis, et al 2005 for a discussion of 
inverted U-shape functions of dopaminergic actions also 
relevant to the present observation). Thus, as speculated 
for subjects with a schizotypal personality disorder (Siever 
and Davis 2004), protective brain mechanisms might play 
a role in more moderate forms of schizotypy, ie, high scor-
ers on the MI scale (see Mohr et al 2004; Mohr, Landis, 
et al 2005 for a more detailed account on this argument). 
This may explain why even large longitudinal studies 
on subjects with high MI scores, as undertaken by the 
Chapman group (Chapman et al 1994; Kwapil et al 1997), 
failed to convincingly predict a later psychotic breakdown 
from elevated positive schizotypal features alone (see also 
Verdoux and van Os 2002). In fact, it appears to need more 
than just being schizotypal (ie, negative environmental life 
events) to possibly turn a potential genetic predisposition 
for psychosis into severe mental illness (eg, Meehl 1989; 
Jang et al 2005).
Conclusion
We summarize the main ﬁ  ndings from our admittedly com-
plex study design by suggesting that
1)  levodopa focuses SSA in neuronal networks according 
to the semantic specialization of the two hemispheres. 
For RVF (left hemisphere) presentation, access to more 
directly related semantic concepts is facilitated, while 
access to unrelated semantic concepts is rendered more 
difﬁ  cult. On the other hand, SSA is unconstrained by 
levodopa in the RH.
2) Lateralized semantic priming is modulated by indi-
viduals’ positive schizotypal features (Pizzagalli et al 
2001). High MI scorers in the placebo group evidenced 
facilitated access to remotely associated concepts when 
targets were presented to the LVF (right hemisphere). 
However, a similar performance was observed in low 
MI scorers in the levodopa group. On the other hand, 
high MI scorers in the levodopa group evidenced 
direct and indirect semantic priming after either visual Neuropsychiatric Disease and Treatment 2006:2(1) 83
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ﬁ  eld presentation, a performance pattern observed in 
low MI scorers in the placebo group. The slope of 
lexical decision latencies in high MI scorers in the 
levodopa group was a result of particularly long RTs 
to unrelated prime-target pairs. Thus, variations in 
cognitive performance as well as their modulation by 
pharmacological agents depend in important ways on 
individual differences (Fleming et al 1995; Kosslyn 
et al 2000), ie, belief in magical causations, in the 
present case.
3)  We observed an inverse task performance in high and 
low MI scorers in the levodopa as compared with the 
placebo group. Discrepancies between previous ﬁ  nd-
ings from semantic priming studies with patients with 
schizophrenia and the present results concerning healthy 
participants’ schizotypal features were also emphasized. 
We think that both these inconsistencies are meaningful 
in that they add further evidence to previous notions of 
protective brain mechanisms along the schizophrenia 
spectrum (Mohr et al 2004; Siever and Davis 2004; Mohr, 
Landis, 2005).
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